Global Consumer Healthcare market is valued at approximately USD 539.59 billion in 2023 and is anticipated to expand at a robust CAGR of 6.78% over the forecast period from 2024 to 2032. Request To ...
The situation is extremely desperate... humanitarian access and supplies remain severely restricted,’ the medics tell Bel ...
Mario Tama / Getty Images The S&P 500—the Standard & Poor's 500 Index—is considered to be one of the best measures of U.S. stock market performance, tracking 500 of the largest and most ...
In its August 2024 report, the CDSCO identified over 50 drugs as Not of Standard Quality (NSQ), including popular medicines ...
More than 50 drugs which include paracetamol, Calcium, vitamin D3 supplements, anti-diabetes pills, and high blood pressure ...
CDSCO flags over 50 drugs, including paracetamol, as substandard, raising serious health concerns In a concerning development ...
11d
Apart from hurting at the domestic level, the trend will further tarnish the reputation of India in the global arena ...
The company shares, however, found a boost in ratings issued by brokerage firms. UBS' brokerage arm, which issued a 'Sell' call for major pharma companies, including Zydus, Aurobindo and Lupin, ...
The drug regulator's quality tests cover top-selling drugs like Vitamin C, D3 Tablet Shelcal, Vitamin B Complex, Anti ...
Some of the well-known medicines mentioned in the list were antiacid Pan-D, Paracetamol, blood pressure (BP ... it carried ...
The Central Drugs Standard Control Organisation (CDSCO) has listed samples of more than 50 drugs, including paracetamol, Pan ...
11d
High blood pressure medications Telmisartan and Atropine Sulphate and antibiotics such as Amoxicillin And Potassium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback